Picture of BioXcel Therapeutics logo

BTAI BioXcel Therapeutics Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Annual balance sheet for BioXcel Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Cash and Short Term Investments0.88742.632.4213233
Prepaid Expenses
Total Other Current Assets
Total Current Assets0.8943.234.1217237
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment0.0040.3272.232.782.54
Other Long Term Assets
Total Assets1.3543.536.4220239
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities2.344.668.4711.816.7
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities2.344.669.513.217.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity-0.98238.926.9207222
Total Liabilities & Shareholders' Equity1.3543.536.4220239
Total Common Shares Outstanding

Or unlock with your email

Or unlock with your email